Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1245823-50-0
1286281-32-0
1446282-18-3
149577-05-9
1818294-42-6
209542-49-4
1820574-15-9 | (R)-2-(2,2-Diisopropyl-1,3-dioxolan-4-yl)ethanol | AA00I0AD | MFCD22041646
1820640-19-4 | N,N-Bis(BOC)-5-chloro-4-methyl-2-nitroaniline | AA00I0J9 | MFCD26523321
1820684-56-7 | 4-(Methoxy-d3)aniline hydrochloride | AA00I0R1 | MFCD28385203
1820717-21-2 | 4-Chloro-5-methyl-1,3-benzoxazol-2-amine | AA00I0YY | MFCD28101660
1823834-07-6 | tert-Butyl 4-fluoro-3-oxoazepane-1-carboxylate | AA00I17R | MFCD27997495
1845690-62-1 | 6-Bromo-4-fluoro-1-N-methylbenzene-1,2-diamine | AA00I1EQ | MFCD28962792
18650-13-0 | 2,15-Hexadecanedione | AA00I1QT | MFCD00039837
1881331-56-1 | 3-chloro-5-ethoxyphenol | AA00I2KV | MFCD29044455
19346-17-9 | 2,3,6,7,8,9-Hexahydro-1h-cyclopenta[a]naphthalen-1-one | AA00I2VJ | MFCD20462271
1951441-78-3 | 3-Bromo-5-(dimethoxymethyl)benzoic acid | AA00I37F | MFCD29764405